NVLN - Novelion Therapeutics Inc.
Previous close
0.68
0.680 100.000%
Share volume: 0
Last Updated: Tue 08 Oct 2019 10:00:00 PM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Fundamental analysis
44%
Profitability
51%
Dept financing
40%
Liquidity
5%
Performance
48%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Stock price
$0.68
DAY RANGE
$0.68 - $0.68
52 WEEK RANGE
$0.55 - $2.35
52 WEEK CHANGE
-$45.47
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Benjamin J. Harshbarger
Region: US
Website: http://www.novelion.com
Employees: 109
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology
Region: US
Website: http://www.novelion.com
Employees: 109
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology
Novelion Therapeutics, Inc. engages in the development and commercialization of pharmaceuitical products. It focuses in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and is headquartered in Vancouver, Canada.
Recent news